WHO announces start of Ebola vaccine clinical trial in DR Congo
The WHO announced the start of the first clinical trial of an Ebola vaccine in the outbreak in the Democratic Republic of Congo. Participants were vaccinated with the Ervebo vaccine in Bunia, Ituri province, the outbreak's epicentre, under the Tumaini trial framework. The outbreak, declared in May, has reported more than 9,700 cases and over 4,600 deaths and has spread to four African countries.
5
Divergence score
2 outlets covered it, splitting into 2 framing camps across 1 bias group.
2 camps
1 bias group
The spectrum · how 2 outlets placed this story
LeftCenterRight
Al Jazeera
Le Monde
Supportive of action
Neutral
Dismissive
Critical
Alarmist
International angle
Widest split · the two outlets furthest apart, and who published first
First to report
- Le Mondefirst
- Al Jazeera+1.6 h
By each outlet's earliest publish time in this story. Feeds that index slowly can appear later than they printed.
The split, in one line
Both outlets report the same launch in Bunia; one frames it as a first clinical trial with Ervebo, the other simply says the trial begins. The gap is detail, not narrative.
How each outlet covered it
No left-right split here
Coverage clusters in the center and international press. Here is each take as it stands.
Center & international coverage
“WHO announces start of Ebola vaccine clinical trial in DR Congo”
“Ebola vaccine trial begins in DR Congo”
4 tracked claims across 2 outlets
Fact ledger
All4Claimed2Corroborated2
1/2
Claimed
The trial is the Tumaini framework testing multiple vaccines, including Oxford and Moderna Bundibugyo candidates
Corroborated
Disputed
3 more tracked claimsSign up free to see the full ledger